Hezong Medicine Easy-To-Buy Pharmaceutical issued a profit warning, expecting an annual net profit of 14.5 million to 19.5 million yuan, a year-on-year decrease of 67.24% to 75.64%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Hezong Medicine Easy-To-Buy Pharmaceutical disclosed its performance forecast for the year 2024. The company expects a net profit attributable to shareholders of the listed company to be between 14.5 million yuan and 19.5 million yuan, a year-on-year decrease of 67.24% to 75.64%; the net profit after deducting non-recurring gains and losses is expected to be between 8.75 million yuan and 12.75 million yuan, a year-on-year decrease of 76.40% to 83.81%
According to the Zhitong Finance APP, Hezong Medicine Easy-To-Buy Pharmaceutical (300937.SZ) disclosed its performance forecast for 2024, expecting a net profit attributable to shareholders of the listed company to be between 14.5 million and 19.5 million yuan, a year-on-year decrease of 67.24% to 75.64%; the net profit after deducting non-recurring gains and losses is expected to be between 8.75 million and 12.75 million yuan, a year-on-year decrease of 76.40% to 83.81%